Triple Insulin Therapy Helps Diabetics

Published Online: Wednesday, September 1, 2004

Patients with type 2 diabetes show improved glucose control using insulin and 2 types of insulin-sensitizing drugs (metformin and troglitazone), without triggering weight gain. The study, which involved 28 participants, compared dual therapy with triple therapy. The results of the study found that control of glucose levels improved with dual therapy and further improved after 4 months of triple therapy. Also, triple drug therapy was linked with a major decrease in total daily insulin dose, reported the authors in Diabetes Care (July 2004).

For the study, the participants initially assigned to take insulin and troglitazone gained an average of 10 pounds after 4 months, but no additional weight was gained when metformin was added. The researchers noted, however, that the participants who took insulin and metformin did not gain weight during the initial 4 months or during the 4 months after troglitazone was added.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues